RxDoctor Payments Data

Christine Walsh, MD

Gynecologic Oncology · Aurora, CONPI 1083666721

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,840 of the $7,978 with a category attached, or 85.7%. 7 manufacturers reported payments, led by Regeneron at 54.6% of the total. 2023 is the largest year on record at $4,471, 5.8 times the $768 reported in 2019.

$7,978in general payments, 2019–2025

Across 17 payments — averaging $469.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$4K
  • Genentech, Inc.$3K
  • Intuitive Surgical$707
  • Merck$129
  • GSK$94
  • AstraZeneca$31
  • plus $21 from 1 others
$467,749in research payments, 2019–2025

Across 4 payments — averaging $116,937 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$468K

What the payments were for

  • Consulting fees$6,84086%
  • Food & beverage$1,10214%
  • Education$360%

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,978 in reported general payments places this provider in the 65th percentile of 28 gynecologic oncology providers in Colorado.

See all gynecologic oncology providers in Colorado

Medicare billing

Part B allowed, 2024
$59,590
Medicare patients
120
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →